Safety and performance of Magmaris at 24-month follow-up of BIOSOLVE-IV
TORZEWSKI J. (1), WLODARCZAK A. (2), MONTORSI P. (3), BENNETT J. (4), HAUDE M. (5), STARMER G. (6), BUCK T. (7), WIEMER M. (8), VERHEYE S. (9), KANG-YIN LEE M. (10)
(1) Cardiovascular Center Oberallgaeu-Kempten, Oberallgaeu, GERMANY (2) Miedziowe Centrum Zdrowia S.A., Lubin POLAND (3) Centro Cardiologico Monzino, Milan ITALY (4) University Hospitals Leuven, Leuven BELGIUM (5) Staedtische Kliniken Neuss - Lukaskrankenhaus GmbH, Neuss GERMANY (6) Cairns Hospital, Cairns AUSTRALIA (7) Klinikum Westfalen, Knappschaftskrankenhaus, Dortmund GERMANY (8) University Hospital Johannes Wesling Minden, Minden GERMANY (9) Antwerp Cardiovascular Center, ZNA Middelheim, Antwerp BELGIUM (10) Queen Elizabeth Hospital, Hong Kong HONG KONG